MIRA INFORM REPORT

 

 

Report No. :

352847

Report Date :

04.12.2015

 

IDENTIFICATION DETAILS

 

Name :

COPAD EGYPT FOR TRADE AND PHARMACEUTICAL INDUSTRIES

 

 

Registered Office :

Masaken Sheraton, Plot 4, Square 1169, Heliopolis, Cairo

 

 

Country :

Egypt

 

 

Financials (as on) :

31.12.2014

 

 

Year of Establishment :

1991

 

 

Com. Reg. No.:

268677

 

 

Legal Form :

Egyptian Joint Stock Company

 

 

Line of Business :

Import and Distribution of Pharmaceutical Preparations.

 

 

No. of Employees :

250

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limits :

US$ 250,000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Egypt

B2

B2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 


 

EGYPT - ECONOMIC OVERVIEW

 

Occupying the northeast corner of the African continent, Egypt is bisected by the highly fertile Nile valley, where most economic activity takes place. Egypt's economy was highly centralized during the rule of former President Gamal Abdel NASSER but opened up considerably under former Presidents Anwar EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008 pursued business climate reforms to attract foreign investment and facilitate growth. Poor living conditions and limited job opportunities for the average Egyptian contribute to public discontent, a major factor leading to the January 2011 revolution that ousted Mubarak. The uncertain political, security, and policy environment since 2011 caused economic growth to slow significantly, hurting tourism, manufacturing, and other sectors and pushing up unemployment. Weak growth and limited foreign exchange earnings have made public finances unsustainable, leaving authorities dependent on expensive borrowing for deficit finance and on Gulf allies to help cover the import bill. Egypt's current Constitution passed in a referendum that took place in January 2014.

 

Source : CIA

 

SUMMARY

 

Company Name                                    : COPAD EGYPT FOR TRADE AND PHARMACEUTICAL INDUSTRIES

Country of Origin                                   : Egypt

Legal Form                                           : Egyptian Joint Stock Company

Registration Date                                  : 1991

Commercial Registration Number           : 268677

Tax Card Number                                  : 332-326-543

Issued Capital                                       : £E 29,800,000

Paid up Capital                                     : £E 29,800,000

Total Workforce                                     : 250

Activities                                               : Distributors of pharmaceutical preparations.

Financial Condition                                : Fair

Payments                                             : Nothing detrimental uncovered

Operating Trend                                    : Steady

Recommended Credit Limit                    : US$ 250,000

Person Interviewed                                : Khaled Ali Mohamed, General Manager

 


COMPANY NAME

 

COPAD EGYPT FOR TRADE AND PHARMACEUTICAL INDUSTRIES

 

 

ADDRESS

 

Registered & Physical Address

 

Location           : Masaken Sheraton, Plot 4, Square 1169, Heliopolis

 

Town                : Cairo

Country             : Egypt

 

Telephone         : (20-2) 22689214 / 22689212 / 22689213 / 22689215 / 22689216 / 22689217

Facsimile          : (20-2) 22689210

Mobile              : (20-122) 4544592

Email                : eng_khaledali@hotmail.com / info@copadpharma.com / khaled.ali@copadpharma.com

 

Please note that the above address is correct. “4 Quare No 1169 Bis, Sheraton Helipolis Area” is incorrect.

 

Premises

 

Subject operates from a large suite of offices that are rented and located in the Central Business Area of Cairo.

 

Branch Office (s)

 

     Location                                                                                           Description

 

·       Industrial Zone, Plot No. 12011                                                          Factory premises

Cairo / Ismailia Road

El Obour

Cairo

Tel: (20-2) 46652445 / 44891448

Fax: (20-2) 46652449

 

·       11 Emad El Din Street                                                                      Office premises                                                El Azbakia

Cairo

Tel: (20-2) 25897719 / 25892030

Fax: (20-2) 25890250

 

 

KEY PRINCIPALS

 

     Name                                                                                               Position

 

·       Mahmoud Hosny Abd El Kader                                                         Chairman

 

·       Ahmed Mahmoud Hosny Abd El Kader                                              Vice Chairman

 

·       Emad Abd El Moniem                                                                       Finance Manager

 

·       Khaled Ali Mohamed                                                                         General Manager

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 1991

 

Legal Form                  : Egyptian Joint Stock Company

 

Commercial Reg. No.   : 268677

 

Tax Card No.                : 332-326-543

 

Issued Capital              : £E 29,800,000

 

Paid up Capital            : £E 29,800,000

 

Name of Shareholder (s)                                Percentage

 

·       Ahmed Mahmoud Hosny Abd El Kader                      66%

 

·       Mahmoud Hosny Abd El Kader                                 12%

 

·       Wedad Mahmoud Hosny                                           12%

 

·       Mahmoud Hosny                                                      10%

 

 

OPERATIONS

 

Activities: Engaged in the import and distribution of pharmaceutical preparations.

 

Import Countries: France, China, India, Netherlands and Germany.

 

Agencies Held:

 

·       Isigny Saint-Mere                              France

·       Laboratoires Biove                           France

·       Newnordic                                        Denmark

·       Pura Life Medical                              United States of America

·       Omega                                             Canada

·       Metromed                                        United Arab Emirates

·       Oman Euro Food Industries              Oman

 

Operating Trend: Steady

 

Subject has a workforce of approximately 250 employees.

 

 

FINANCIAL DATA

 

Financial highlights provided by local sources are given below:

 

Currency: Egyptian Pounds (£E)

 

                                    Year Ending 31/12/13:               Year Ending 31/12/14:

 

Total Sales                    £E 41,200,000                           £E 43,450,000

 

Local sources consider subject’s financial condition to be Fair.

 

The above financial figures are based on estimations by our local sources.

 

 

BANKERS

 

·       Commercial International Bank (CIB)

Nile Tower Building

21-23 Giza Street

PO Box: 2430

Cairo

Tel: (20-2) 25703043

Fax: (20-2) 25703172 / 25072691

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

CREDIT RATING

 

Recommended credit limit:                  US$ 250,000

 

 

GENERAL COMMENTS

 

During the course of this investigation nothing detrimental was uncovered regarding subject’s operating history or the manner in which payments are fulfilled. As such the company is considered to be a fair trade risk.

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.75

UK Pound

1

Rs.99.61

Euro

1

Rs.70.67

EGP

1

Rs.8.55

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

KAR

 

 

Report Prepared by :

NIT

 

               


 

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.